July 3, 2022

Compassionate use: Putting drug regulations to the test

When should pharmaceutical companies grant compassionate use of experimental treatments? How readily available should the drugs be? A PBS news segment considers these issues.

When should pharmaceutical companies give gravely ill patients access to experimental treatments? The above news segment offers an good summary of the issues involved in this vexed ethical dilemma. 

Compassionate Use Putting drug regulations to the test
Xavier Symons
https://www.bioedge.org/images/2008images/TH_savejosh.jpg
Creative commons
clinical trials
compassionate use